NV
Northpond Ventures Portfolio holdings
AUM
$43.7M
This Quarter Return
-14%
1 Year Return
-34.02%
3 Year Return
-71.84%
5 Year Return
–
10 Year Return
–
AUM
$43.7M
AUM Growth
+$43.7M
(-21%)
Cap. Flow
-$2M
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
TBIO
Telesis Bio, Inc. Common Stock
TBIO
|
$2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kyverna Therapeutics
KYTX
$160M
| $15.9M | 36.46% | 3,255,426 | – | – |
|
|
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
| $14.3M | 32.82% | 4,214,498 | – | – |
|
3
Candel Therapeutics
CADL
$318M
| $13.4M | 30.72% | 1,935,215 | – | – |
|
|
TBIO
4
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| – | – | -546,897 | Closed | -$2M |
|